Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Risk factors for bleeding and clinical implications in patients undergoing liver transplantation.

Esmat Gamil M, Pirenne J, Van Malenstein H, Verhaegen M, Desschans B, Monbaliu D, Aerts R, Laleman W, Cassiman D, Verslype C, Van Steenbergen W, Van Pelt J, Nevens F.

Transplant Proc. 2012 Nov;44(9):2857-60. doi: 10.1016/j.transproceed.2012.09.085.

PMID:
23146542
2.

The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.

de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, Porte RJ.

Anesth Analg. 2008 Jan;106(1):32-44, table of contents. doi: 10.1213/01.ane.0000289638.26666.ed.

PMID:
18165548
3.

Duration of red blood cell storage and outcomes following orthotopic liver transplantation.

Dunn LK, Thiele RH, Ma JZ, Sawyer RG, Nemergut EC.

Liver Transpl. 2012 Apr;18(4):475-81. doi: 10.1002/lt.23379.

5.

Rotational Thromboelastometry or Conventional Coagulation Tests in Liver Transplantation: Comparing Blood Loss, Transfusions, and Cost.

Smart L, Mumtaz K, Scharpf D, Gray NO, Traetow D, Black S, Michaels AJ, Elkhammas E, Kirkpatrick R, Hanje AJ.

Ann Hepatol. 2017 November-December,;16(6):916-923. doi: 10.5604/01.3001.0010.5283.

6.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
7.

Coagulation defects do not predict blood product requirements during liver transplantation.

Massicotte L, Beaulieu D, Thibeault L, Roy JD, Marleau D, Lapointe R, Roy A.

Transplantation. 2008 Apr 15;85(7):956-62. doi: 10.1097/TP.0b013e318168fcd4.

PMID:
18408574
8.

The impact of operative bleeding on outcome in transplantation of the liver.

Mor E, Jennings L, Gonwa TA, Holman MJ, Gibbs J, Solomon H, Goldstein RM, Husberg BS, Watemberg IA, Klintmalm GB.

Surg Gynecol Obstet. 1993 Mar;176(3):219-27.

PMID:
8438192
9.

Preoperative factors as predictors of blood product transfusion requirements in orthotopic liver transplantation.

Ghaffaripour S, Mahmoudi H, Khosravi MB, Sahmeddini MA, Eghbal H, Sattari H, Kazemi K, Malekhosseini SA.

Prog Transplant. 2011 Sep;21(3):254-9.

PMID:
21977887
10.

Liver retransplantation for ischemic-type biliary lesions after orthotopic liver transplantation: a clinical report of 66 cases.

Zhu ZJ, Rao W, Sun JS, Cai JZ, Deng YL, Zheng H, Zhang YM, Jiang WT, Zhang JJ, Gao W, Shen ZY.

Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):471-5.

11.

Analysis of liver transplantation outcome in patients with MELD Score > or = 30.

Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Meira-Filho SP, Rezende MB, Paes AT, Afonso RC.

Transplant Proc. 2008 Apr;40(3):797-9. doi: 10.1016/j.transproceed.2008.03.016.

PMID:
18455020
12.

Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.

Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, Ilmakunnas M, Koivusalo AM, Isoniemi H, Strengers PF, Groen H, Hendriks HG, Lisman T, Pirenne J, Porte RJ.

BMC Surg. 2013 Jul 1;13:22. doi: 10.1186/1471-2482-13-22.

13.

The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.

Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.

Liver Transpl. 2011 Jun;17(6):674-84. doi: 10.1002/lt.22228.

14.

Orthotopic liver transplantation in patients with portal vein thrombosis in the absence of hepatocellular carcinoma.

Fouzas I, Paul A, Becker C, Vernadakis S, Treckmann JW, Máthé Z, Gerken G, Sotiropoulos GC.

Transplant Proc. 2012 Nov;44(9):2734-6. doi: 10.1016/j.transproceed.2012.09.024.

PMID:
23146508
15.

High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.

Suzuki H, Bartlett AS, Muiesan P, Jassem W, Rela M, Heaton N.

Transplant Proc. 2012 Mar;44(2):384-8. doi: 10.1016/j.transproceed.2011.11.013.

PMID:
22410023
16.

Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.

Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A.

Liver Transpl. 2006 Jan;12(1):117-23. Erratum in: Liver Transpl. 2006 Apr;12(4):694.

17.

Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center.

Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Nozza A, Lapointe R, Roy A.

Transplantation. 2012 Jun 27;93(12):1276-81. doi: 10.1097/TP.0b013e318250fc25.

PMID:
22617090
18.

Strong impact of acute kidney injury on survival after liver transplantation.

Zhu M, Li Y, Xia Q, Wang S, Qiu Y, Che M, Dai H, Qian J, Ni Z, Axelsson J, Yan Y.

Transplant Proc. 2010 Nov;42(9):3634-8. doi: 10.1016/j.transproceed.2010.08.059.

PMID:
21094830
19.

Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.

Umbro I, Tinti F, Mordenti M, Rossi M, Ianni S, Pugliese F, Ruberto F, Ginanni Corradini S, Nofroni I, Poli L, Berloco PB, Mitterhofer AP.

Transplant Proc. 2011 May;43(4):1139-41. doi: 10.1016/j.transproceed.2011.02.045.

PMID:
21620072
20.

Blood transfusion requirement during liver transplantation is an important risk factor for mortality.

Rana A, Petrowsky H, Hong JC, Agopian VG, Kaldas FM, Farmer D, Yersiz H, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2013 May;216(5):902-7. doi: 10.1016/j.jamcollsurg.2012.12.047. Epub 2013 Mar 9.

PMID:
23478547

Supplemental Content

Support Center